iBio Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Details)

Stockholders' Equity (Details)																			1 Months Ended						3 Months Ended	6 Months Ended
Stockholders' Equity (Details)	Feb. 07, 2020 USD ($) shares	Jan. 01, 2020 USD ($) shares	Oct. 29, 2019 USD ($) $ / shares shares	Oct. 28, 2019 USD ($) $ / shares shares	Oct. 01, 2019 shares	Sep. 30, 2019 shares	Jul. 12, 2018 USD ($) $ / shares shares	Jun. 26, 2018 USD ($) $ / shares shares	Jun. 20, 2018 $ / shares shares	Jan. 26, 2018	Nov. 30, 2017 USD ($) $ / shares shares	Nov. 27, 2017	Jul. 24, 2017 USD ($) item $ / shares shares	Feb. 23, 2017 USD ($) $ / shares shares	Apr. 13, 2016 USD ($) shares	Jan. 25, 2016 USD ($) shares	Jan. 13, 2016 USD ($) $ / shares shares	Jan. 14, 2014	Feb. 08, 2020 USD ($) shares	Oct. 29, 2019 $ / shares shares	Mar. 31, 2019	Nov. 30, 2018 USD ($)	May 31, 2018 USD ($)	Mar. 31, 2018 USD ($) shares	Dec. 31, 2019 USD ($) $ / shares shares	Dec. 31, 2019 USD ($) $ / shares shares	Dec. 31, 2018 USD ($) shares	Jun. 30, 2019 USD ($) $ / shares shares	Sep. 30, 2018 shares	Jun. 30, 2018 shares	Dec. 19, 2017 shares	Dec. 31, 2015
Stockholders' Equity [Line Items]
Preferred Stock, Shares Authorized																									1,000,000	1,000,000
Shares exchanged for ownership interest														29,990,000
Noncontrolling Interest, Amount Represented by Preferred Stock \| $														$ 13,000,000
Acquisition Of Equity Interest, Units Receivable Per Preferred Share																										29,990,000
Common Stock, Par or Stated Value Per Share \| $ / shares				$ 1,000					$ 1,000																$ 0.001	$ 0.001		$ 0.001
Shares Issued, Price Per Share \| $ / shares											$ 2.00
Stock Issued During Period, Shares, New Issues								4,350,000			2,250,000
Stock Issued During Period, Value, New Issues \| $								$ 16,000,000			$ 4,500,000
Common Stock, Shares Authorized																									275,000,000	275,000,000		275,000,000
Common Stock, Capital Shares Reserved for Future Issuance																									2,240,000	2,240,000
Proceeds from Issuance of Common Stock \| $			$ 4,520,000
Adjustments to Additional Paid in Capital, Deemed Dividends \| $																									$ 0	$ 21,560,000	$ 0
Agreement term																		5 years
Common Stock, Shares, Issued													120,000												54,567,455	54,567,455		20,152,458
Share Price \| $ / shares								$ 0.90																	$ 0.25	$ 0.25
Underwriting Discounts, Commissions and Other Offering Expenses \| $							$ 159,000	$ 854,000			$ 311,000
No sales period								90 days
Underwriting option period								45 days
Proceeds from Warrant Exercises \| $	$ 5,400,000	$ 4,760,000																								$ 691,000	$ 0
Proceeds from Noncontrolling Interests \| $																						$ 2,459,000	$ 1,093,000
Stock Issued During Period, Shares, Warrants Exercised		21,615,000																								3,140,000
Series A Warrants [Member]
Stockholders' Equity [Line Items]
Stock Issued During Period, Shares, New Issues			25,000,000
Class of Warrant or Right, Exercise Price of Warrants or Rights \| $ / shares			$ 0.22																	$ 0.22
Number of stocks sold			1
Class Of Warrants Or Rights Exercised	19,400,000
Number of warrants issued			25,000,000																							25,000,000
Exercise price of warrants \| $ / shares			$ 0.22																	$ 0.22
Term of the warrants			2 years																	2 years
Stock Issued During Period, Shares, Warrants Exercised		16,335,000																								3,070,000
Series B Warrants [Member]
Stockholders' Equity [Line Items]
Stock Issued During Period, Shares, New Issues			25,000,000
Class of Warrant or Right, Exercise Price of Warrants or Rights \| $ / shares			$ 0.22																	$ 0.22
Number of stocks sold			1
Class Of Warrants Or Rights Exercised	5,300,000
Number of warrants issued			25,000,000																							25,000,000
Exercise price of warrants \| $ / shares			$ 0.22																	$ 0.22
Term of the warrants			7 years																	7 years
Stock Issued During Period, Shares, Warrants Exercised		5,280,000																								70,000
Common Stock [Member]
Stockholders' Equity [Line Items]
Shares Issued, Price Per Share \| $ / shares								$ 0.90	$ 0.90
Stock Issued During Period, Shares, New Issues			2,450,000					4,350,000												2,450,000
Conversion of Stock, Shares Issued			22,450,000		13,000																					5,874,997
Common Stock, Shares Authorized																															275,000,000
Adjustments to Additional Paid in Capital, Deemed Dividends \| $																									$ 0
Shares, Outstanding						24,152,000																			54,567,000	54,567,000	18,837,000	20,152,000	18,337,000	16,040,000
Number of stock issued on each unit of stock sold			1
Stock Issued During Period, Shares, Warrants Exercised																									3,140,000
Preferred Stock [Member]
Stockholders' Equity [Line Items]
Adjustments to Additional Paid in Capital, Deemed Dividends \| $																									$ 0
Shares, Outstanding						6,000																			6,000	6,000	11,000	10,000	11,000	12,000
Warrant [Member]
Stockholders' Equity [Line Items]
Common Stock, Capital Shares Reserved for Future Issuance																									25,250,000	25,250,000
Number of stocks sold			2
Common Stock and Warrants [Member]
Stockholders' Equity [Line Items]
Shares Issued, Price Per Share \| $ / shares			$ 0.20																	$ 0.20
Preferred Tracking Stock [Member]
Stockholders' Equity [Line Items]
Stock Issued During Period, Shares, Acquisitions														1
Shares exchanged for ownership interest														1
Preferred Stock, Dividend Rate, Percentage																										2.00%
Preferred Stock, Dividends Per Share, Declared \| $ / shares																										$ 0
Dividends Payable \| $																									$ 741,000	$ 741,000		$ 610,000
Preferred Stock, Par or Stated Value Per Share \| $ / shares														$ 0.001
Series A Preferred Stock [Member]
Stockholders' Equity [Line Items]
Preferred Stock, Shares Authorized									1,000,000																6,300	6,300		6,300
Convertible Preferred Stock, Terms of Conversion																										Each share of Series A Preferred is convertible into an amount of shares of common stock determined by dividing the stated value of $1,000 by the conversion price in effect at such time. The original conversion price of $0.90 was adjusted to $0.20 upon the closing of the Company's public offering on October 29, 2019. See the sections below entitled "Public Offering - Alliance - June 26, 2018" and "Public Offering - Alliance - October 29, 2019" for further information. The number of shares of common stock to be received is limited by the beneficial ownership limitation as defined in the certificate of designation. Subject to limited exceptions, a holder of Series A Preferred will not have the right to exercise any portion of its Series A Preferred if such holder, together with its affiliates, would beneficially own over 4.99% of the number of shares of our common stock outstanding immediately after giving effect to such exercise; provided, however, that upon 61 days' prior notice to us, such holder may increase such limitation, provided that in no event will the limitation exceed 9.99%.
Dividends Payable \| $																									$ 0	$ 0
Preferred Stock, Par or Stated Value Per Share \| $ / shares									$ 0.001
Maximum ownership through conversion without prior notice									4.99%
Notice period									61 days
Maximum ownership through conversion with prior notice									9.99%
Stock Issued During Period, Shares, New Issues								6,300
Conversion of Stock, Shares Converted					12																					3,975
Conversion Of Preferred Stock, Conversion Price Per Share \| $ / shares																										$ 0.20
Common Stock, Capital Shares Reserved for Future Issuance																									0	0
Share Price \| $ / shares								$ 1,000
Series B Preferred Stock [Member]
Stockholders' Equity [Line Items]
Preferred Stock, Shares Authorized									1,000,000																5,785	5,785		5,785
Convertible Preferred Stock, Terms of Conversion																										Each share of Series B Preferred is convertible into an amount of shares of common stock determined by dividing the stated value of $1,000 by the conversion price in effect at such time. The original conversion price of $0.90 was adjusted to $0.20 upon the closing of the Company's public offering on October 29, 2019. See the sections below entitled "Public Offering - Alliance - June 26, 2018" and "Public Offering - Alliance - October 29, 2019" for further information. The number of shares of common stock to be received is limited by the beneficial ownership limitation as defined in the certificate of designation. Subject to limited exceptions, a holder of Series B Preferred will not have the right to exercise any portion of its Series B Preferred if such holder, together with its affiliates, would beneficially own over 48% of the number of shares of our common stock outstanding immediately after giving effect to such exercise.
Preferred Stock, Par or Stated Value Per Share \| $ / shares									$ 0.001
Shares Issued, Price Per Share \| $ / shares			$ 0.20						$ 0.90											0.20
Stock Issued During Period, Shares, New Issues								5,785
Conversion of Stock, Shares Converted																										0
Maximum Common Stock Percentage									48.00%
Conversion Of Preferred Stock, Conversion Price Per Share \| $ / shares																										$ 0.20
Common Stock, Capital Shares Reserved for Future Issuance																									28,925,000	28,925,000
Share Price \| $ / shares								$ 1,000
Series C Preferred Stock [Member]
Stockholders' Equity [Line Items]
Preferred Stock, Shares Authorized				1,000,000																					4,510	4,510		4,510
Convertible Preferred Stock, Terms of Conversion																										Each share of Series C Preferred is convertible into an amount of shares of common stock determined by dividing the stated value of $1,000 by the conversion price of $0.20, subject to adjustment. The number of shares of common stock to be received is limited by the beneficial ownership limitation as defined in the certificate of designation. Subject to limited exceptions, a holder of Series C Preferred will not have the right to exercise any portion of its Series C Preferred if such holder, together with its affiliates, would beneficially own over 4.99% (or, upon election by a holder prior to the issuance of any Series C Preferred Shares, 9.99%) of the number of shares of our Common Stock outstanding immediately after giving effect to such exercise; provided, however, that upon prior notice to us, such holder may increase such limitation, provided that in no event will the limitation exceed 9.99% and any such increase will not be effective until the 61st day after such notice is delivered to the Company.
Dividends Payable \| $				$ 0
Preferred Stock, Par or Stated Value Per Share \| $ / shares				$ 0.001
Shares Issued, Price Per Share \| $ / shares				$ 0.20
Stock Issued During Period, Shares, New Issues			4,510																						4,490
Maximum Common Stock Percentage				4.99%
Maximum ownership through conversion without prior notice, prior to the issuance of preferred shares				9.99%
Common Stock, Capital Shares Reserved for Future Issuance																									100,000	100,000
Series C Preferred Shares, and Warrants [Member]
Stockholders' Equity [Line Items]
Shares Issued, Price Per Share \| $ / shares			$ 1,000																	$ 1,000
Over-Allotment Option [Member]
Stockholders' Equity [Line Items]
Shares Issued, Price Per Share \| $ / shares							$ 0.90
Stock Issued During Period, Shares, New Issues							1,500,000
Stock Issued During Period, Value, New Issues \| $							$ 1,350,000
Proceeds from Issuance of Common Stock \| $							$ 1,350,000
Sale Of Stock Number Of Shares Offered For Sale								2,666,666
Underwritten Public Offering [Member]
Stockholders' Equity [Line Items]
Proceeds from Issuance of Common Stock \| $			$ 5,000,000
Subsequent Event [Member] \| Underwritten Public Offering [Member]
Stockholders' Equity [Line Items]
Proceeds from Warrant Exercises \| $																			$ 4,700,000
Subsequent Event [Member] \| Underwritten Public Offering [Member] \| Series A Warrants [Member]
Stockholders' Equity [Line Items]
Stock Issued During Period, Shares, Warrants Exercised																			16,300,000
Subsequent Event [Member] \| Underwritten Public Offering [Member] \| Series B Warrants [Member]
Stockholders' Equity [Line Items]
Stock Issued During Period, Shares, Warrants Exercised																			5,300,000
Subsequent Event [Member] \| Underwritten Public Offering [Member] \| Warrant [Member]
Stockholders' Equity [Line Items]
Stock Issued During Period, Shares, Warrants Exercised																			21,600,000
Eastern Share Purchase Agreements [Member]
Stockholders' Equity [Line Items]
Stock Issued During Period, Shares, Acquisitions																	350,000
Shares Issued, Price Per Share \| $ / shares																	$ 6.22
Stock Issued During Period, Shares, New Issues															650,000		650,000
Stock Issued During Period, Value, New Issues \| $															$ 4,043,000	$ 2,177,000
Maximum Common Stock Percentage										48.00%		38.00%					38.00%
Equity Method Investment, Ownership Percentage												40.00%
Agreement term								2 years							3 years
Class Of Warrants Or Rights Exercised																178,400
Proceeds from Warrant Exercises \| $																	$ 945,000
Lincoln Park Purchase Agreement [Member]
Stockholders' Equity [Line Items]
Maximum Common Stock Percentage													9.99%
Share Price \| $ / shares													$ 0.25
Stock Issued During Period, Shares, Other													10,000
Number of days since last purchase													1 day
Number of closing prices \| item													3
Number of consecutive trading days													10 days
Number of shares remaining						14,878,710
Maximum [Member] \| Lincoln Park Purchase Agreement [Member]
Stockholders' Equity [Line Items]
Aggregate Common Stock Purchased \| $													$ 1,000,000
iBio CDMO LLC [Member]
Stockholders' Equity [Line Items]
Shares exchanged for ownership interest														1
Eastern Affiliate [Member]
Stockholders' Equity [Line Items]
Stock Issued During Period, Shares, New Issues																	650,000
Equity Method Investment, Ownership Percentage										40.00%
Lincoln Park Capital Fund, LLC [Member]
Stockholders' Equity [Line Items]
Aggregate Common Stock Issued or Sold													1,781,479
Shares, Outstanding													8,911,851
iBio CMO [Member]
Stockholders' Equity [Line Items]
Noncontrolling Interest, Amount Represented by Preferred Stock \| $																	$ 15,000,000
Noncontrolling Interest, Ownership Percentage by Parent														99.99%																		100.00%
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners																	70.00%
iBio CMO [Member] \| Eastern Affiliate [Member]
Stockholders' Equity [Line Items]
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners														0.01%
Preferred Tracking Stock [Member]
Stockholders' Equity [Line Items]
Stock Issued During Period, Value, New Issues \| $														$ 13,000,000
Convertible Preferred Stock, Shares Issued upon Conversion														29,990,000
Convertible Preferred Stock, Shares Issued upon Conversion														29,990,000
Lincoln Park Capital Fund, LLC [Member]
Stockholders' Equity [Line Items]
Noncontrolling Interest, Ownership Percentage by Parent													19.99%
Stock Issued During Period, Shares, New Issues													250,000											60,000
Stock Issued During Period, Value, New Issues \| $																								$ 121,290
Aggregate Common Stock Purchased \| $													$ 16,000,000
Agreement term													36 months								36 months
Percentage of available shares issued													3.00%
Share Price \| $ / shares													$ 4.00
Lincoln Park Capital Fund, LLC [Member] \| Maximum [Member]
Stockholders' Equity [Line Items]
Stock Issued During Period, Shares, New Issues													1,000,000